TRi-1
TRi-1 is irreversible inhibitor of cytosolic thioredoxin reductase 1 (TXNRD1) with an IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
Product Specifications
CAS Number
246020-68-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
328.72
Molecular Formula
C12H9ClN2O5S
Notes
Research use only, not for human use.
Receptor
TXNRD1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6223084-01 0.1 mL
MAP1S (BPY2IP1, C19orf5, MAP8, VCY2IP1, Microtubule-associated Protein 1S, BPY2-interacting Protein 1, Microtubule-associated Protein 8, Variable Charge Y Chromosome 2-interacting Protein 1, MAP1S Heavy Chain, MAP1S Light Chain, FLJ10669, MGC133087) (MaxL
Ask
View Details 
MBS6223084-02 5x 0.1 mL
MAP1S (BPY2IP1, C19orf5, MAP8, VCY2IP1, Microtubule-associated Protein 1S, BPY2-interacting Protein 1, Microtubule-associated Protein 8, Variable Charge Y Chromosome 2-interacting Protein 1, MAP1S Heavy Chain, MAP1S Light Chain, FLJ10669, MGC133087) (MaxL
Ask
View Details